Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 6/20 | 0.34 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26949660 | 0.83 | RIPK1 (0.34) | RIPK1 | |
| SCHEMBL27284295 | 0.81 | RIPK1 (0.34) | RIPK1 | |
| SCHEMBL26200285 | 0.76 | RIPK1 (0.36) | RIPK1 | |
| SCHEMBL27284023 | 0.73 | RIPK1 (0.36) | RIPK1 | |
| SCHEMBL24312569 | 0.73 | MAP4K4 (0.38) | RIPK1 | |
| SCHEMBL26397269 | 0.70 | RIPK1 (0.30) | RIPK1 | |
| SCHEMBL24058293 | 0.70 | RIPK1 (0.35) | RIPK1 | |
| SCHEMBL23813354 | 0.70 | RIPK1 (0.35) | RIPK1 | |
| SCHEMBL24982191 | 0.69 | ADORA2A (0.35) | RIPK1 | |
| SCHEMBL24057840 | 0.69 | RIPK1 (0.36) | RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210292348-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2021-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210292348-A1 | ANTIVIRAL COMPOUNDS | EIF2AK2, MAVS, DUT | RIPK1 3546/4885DOT1L 653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.